Petrolatum-based, liquid-in-oil suspension technology for eczema
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
85
NCT04951349
Safety and Efficacy of Intranasal Application of GX-03 as a Treatment and Prevention for COVID-19.
Phase: Phase 2
Role: Lead Sponsor
Start: Jan 21, 2021
Completion: May 30, 2021
Loading map...